AGIOS PHARMACEUTICALS, INC. (AGIO)
Nasdaq: AGIO · CIK 0001439222 · United States
Every official AGIOS PHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AGIO filings
AGIOS PHARMACEUTICALS, INC. documents
- AGIOS PHARMACEUTICALS, INC. 10-K 2026AGIO 10-K 2026: annual report for fiscal 2026
- AGIOS PHARMACEUTICALS, INC. 10-K 2025AGIO 10-K 2025: annual report for fiscal 2025
- AGIOS PHARMACEUTICALS, INC. 10-K 2024AGIO 10-K 2024: annual report for fiscal 2024
- AGIOS PHARMACEUTICALS, INC. 10-K 2023AGIO 10-K 2023: annual report for fiscal 2023
- AGIOS PHARMACEUTICALS, INC. 10-K 2022AGIO 10-K 2022: annual report for fiscal 2022
- AGIOS PHARMACEUTICALS, INC. 10-Q 2026AGIO 10-Q 2026: quarterly report for fiscal 2026
- AGIOS PHARMACEUTICALS, INC. 10-Q 2025AGIO 10-Q 2025: quarterly report for fiscal 2025
- AGIOS PHARMACEUTICALS, INC. 10-Q 2024AGIO 10-Q 2024: quarterly report for fiscal 2024
- AGIOS PHARMACEUTICALS, INC. 10-Q 2023AGIO 10-Q 2023: quarterly report for fiscal 2023
- AGIOS PHARMACEUTICALS, INC. 10-Q 2022AGIO 10-Q 2022: quarterly report for fiscal 2022
- AGIOS PHARMACEUTICALS, INC. 8-K 2026AGIO 8-K 2026: current report for fiscal 2026
- AGIOS PHARMACEUTICALS, INC. 8-K 2025AGIO 8-K 2025: current report for fiscal 2025
- AGIOS PHARMACEUTICALS, INC. 8-K 2024AGIO 8-K 2024: current report for fiscal 2024
- AGIOS PHARMACEUTICALS, INC. 8-K 2023AGIO 8-K 2023: current report for fiscal 2023
- AGIOS PHARMACEUTICALS, INC. 8-K 2022AGIO 8-K 2022: current report for fiscal 2022
- AGIOS PHARMACEUTICALS, INC. DEF 14A 2026AGIO DEF 14A 2026: proxy statement for fiscal 2026
- AGIOS PHARMACEUTICALS, INC. DEF 14A 2025AGIO DEF 14A 2025: proxy statement for fiscal 2025
- AGIOS PHARMACEUTICALS, INC. DEF 14A 2024AGIO DEF 14A 2024: proxy statement for fiscal 2024
- AGIOS PHARMACEUTICALS, INC. DEF 14A 2023AGIO DEF 14A 2023: proxy statement for fiscal 2023
- AGIOS PHARMACEUTICALS, INC. DEF 14A 2022AGIO DEF 14A 2022: proxy statement for fiscal 2022
- AGIOS PHARMACEUTICALS, INC. Form 4 2026AGIO Form 4 2026: insider trading filing for fiscal 2026
- AGIOS PHARMACEUTICALS, INC. Form 4 2025AGIO Form 4 2025: insider trading filing for fiscal 2025
- AGIOS PHARMACEUTICALS, INC. Form 4 2024AGIO Form 4 2024: insider trading filing for fiscal 2024
- AGIOS PHARMACEUTICALS, INC. Form 4 2023AGIO Form 4 2023: insider trading filing for fiscal 2023
- AGIOS PHARMACEUTICALS, INC. Form 4 2022AGIO Form 4 2022: insider trading filing for fiscal 2022
- AGIOS PHARMACEUTICALS, INC. S-1 2026AGIO S-1 2026: registration statement for fiscal 2026
- AGIOS PHARMACEUTICALS, INC. S-1 2025AGIO S-1 2025: registration statement for fiscal 2025
- AGIOS PHARMACEUTICALS, INC. S-1 2024AGIO S-1 2024: registration statement for fiscal 2024
- AGIOS PHARMACEUTICALS, INC. S-1 2023AGIO S-1 2023: registration statement for fiscal 2023
- AGIOS PHARMACEUTICALS, INC. S-1 2022AGIO S-1 2022: registration statement for fiscal 2022
- AGIOS PHARMACEUTICALS, INC. 13F 2026AGIO 13F 2026: institutional holdings for fiscal 2026
- AGIOS PHARMACEUTICALS, INC. 13F 2025AGIO 13F 2025: institutional holdings for fiscal 2025
- AGIOS PHARMACEUTICALS, INC. 13F 2024AGIO 13F 2024: institutional holdings for fiscal 2024
- AGIOS PHARMACEUTICALS, INC. 13F 2023AGIO 13F 2023: institutional holdings for fiscal 2023
- AGIOS PHARMACEUTICALS, INC. 13F 2022AGIO 13F 2022: institutional holdings for fiscal 2022
More companies